MANCHESTER KEITH S
Insider CIK 1244828 · ABUS Director · ROIV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | A Award deriv | 2026-09-16 | 2026-09-18 | 10,531 | — | $0 | 10,531 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-09-16 | 2026-09-18 | 5,054 | — | $0 | 1,753,457 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2026-09-16 | 2026-09-18 | 10,531 | — | $0 | 10,531 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-09-16 | 2026-09-18 | 5,054 | — | $0 | 1,753,457 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-30 | 2026-06-30 | 12,380 | $35.28 | $436.8K | 13,689,166 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-30 | 2026-06-30 | 200,000 | $35.45 | $7.09M | 1,748,403 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-29 | 2026-06-30 | 200,000 | $34.44 | $6.89M | 14,301,546 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-29 | 2026-06-30 | 600,000 | $34.59 | $20.75M | 13,701,546 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-26 | 2026-06-30 | 300,783 | $33.92 | $10.20M | 14,826,546 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-26 | 2026-06-30 | 325,000 | $34.07 | $11.07M | 14,501,546 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-13 | 2026-02-13 | 225,000 | $26.50 | $5.96M | 15,127,329 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-13 | 2026-02-13 | 150,784 | $26.49 | $3.99M | 15,352,329 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-12 | 2026-02-13 | 150,000 | $26.72 | $4.01M | 15,778,113 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-12 | 2026-02-13 | 275,000 | $26.76 | $7.36M | 15,503,113 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-02-11 | 2026-02-13 | 425,000 | $26.67 | $11.33M | 15,928,113 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-17 | 2025-12-18 | 155,076 | $23.02 | $3.57M | 16,542,651 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-17 | 2025-12-18 | 432,718 | $23.05 | $9.97M | 16,697,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-17 | 2025-12-18 | 189,538 | $23.17 | $4.39M | 16,353,113 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-16 | 2025-12-18 | 642,282 | $23.08 | $14.82M | 17,130,445 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-12-16 | 2025-12-18 | 275,000 | $22.93 | $6.31M | 17,772,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-19 | 2025-11-21 | 175,000 | $20.24 | $3.54M | 18,047,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-19 | 2025-11-21 | 125,000 | $20.16 | $2.52M | 18,222,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-19 | 2025-11-21 | 150,000 | $20.20 | $3.03M | 18,347,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2025-11-19 | 2025-11-21 | 850,000 | $20.25 | $17.21M | 18,497,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2025-09-10 | 2025-09-12 | 33,726 | — | $0 | 33,726 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-09-10 | 2025-09-12 | 14,524 | — | $0 | 1,948,403 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-06-25 | 2025-06-27 | 1,170,646 | — | $0 | 1,592,480 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-06-25 | 2025-06-27 | 6,837,266 | — | $0 | 0 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-06-25 | 2025-06-27 | 3,176,245 | — | $0 | 19,347,727 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-06-25 | 2025-06-27 | 6,205,368 | — | $0 | 8,441,428 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-09-25 | 2024-09-26 | 134,948 | $11.77 | $1.59M | 1,277,178 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2024-09-24 | 2024-09-26 | 368,052 | $11.63 | $4.28M | 1,412,126 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2024-09-10 | 2024-09-12 | 27,894 | — | $0 | 27,894 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-09-10 | 2024-09-12 | 16,406 | — | $0 | 1,780,178 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise deriv | 2024-08-14 | 2024-08-16 | 54,915 | — | $0 | 0 | SEC↗ |
| ABUS Arbutus Biopharma Corp | M Exercise | 2024-08-14 | 2024-08-16 | 54,915 | $0.56 | $30.8K | 54,915 | SEC↗ |
| ABUS Arbutus Biopharma Corp | S Sale | 2024-08-14 | 2024-08-16 | 8,846 | $3.69 | $32.6K | 46,069 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2024-05-23 | 2024-05-24 | 67,000 | — | $0 | 67,000 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-03-07 | 2024-03-07 | 2,260,661 | — | $0 | 2,763,126 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-03-07 | 2024-03-07 | 5,594,064 | — | $0 | 6,837,266 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-03-07 | 2024-03-07 | 11,325,233 | — | $0 | 23,105,358 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-03-07 | 2024-03-07 | 11,077,765 | — | $0 | 14,646,796 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-09-28 | 2023-10-02 | 3,059,368 | $11.55 | $35.34M | 34,430,591 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-09-28 | 2023-10-02 | 2,285,783 | $11.55 | $26.40M | 25,724,561 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-09-28 | 2023-10-02 | 1,104,599 | $11.55 | $12.76M | 12,431,330 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2023-09-28 | 2023-10-02 | 446,394 | $11.55 | $5.16M | 5,023,787 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2023-09-12 | 2023-09-14 | 26,595 | — | $0 | 26,595 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-09-12 | 2023-09-14 | 17,825 | — | $0 | 69,967 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2023-05-24 | 2023-05-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2022-11-10 | 2022-11-14 | 1,092,355 | $4.75 | $5.19M | 37,489,959 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2022-11-10 | 2022-11-14 | 372,427 | $4.75 | $1.77M | 13,535,929 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2022-11-10 | 2022-11-14 | 2,311,643 | $4.75 | $10.98M | 28,010,344 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2022-11-10 | 2022-11-14 | 146,079 | $4.75 | $693.9K | 5,470,181 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2022-11-09 | 2022-11-14 | 1,196,200 | — | $0 | 38,582,314 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2022-09-15 | 2022-09-19 | 71,850 | — | $0 | 71,850 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2022-09-15 | 2022-09-19 | 52,142 | — | $0 | 52,142 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2022-05-25 | 2022-05-26 | 41,000 | — | $0 | 41,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2021-06-03 | 2021-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2020-05-28 | 2020-06-01 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2019-08-17 | 2019-08-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-06-19 | 2018-06-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2016-06-03 | 2016-06-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2015-08-12 | 2015-08-14 | 7,500 | — | $0 | 7,500 | SEC↗ |